$0.3863
-0.15-28.54%
Last update: Nov 6, 7:59 PM
Lakewood-Amedex Biotherapeutics Inc
LABTNASDAQ
The average analyst price target for Lakewood-Amedex is $3, 688.6% above the current price. The one analyst covering it rates it Buy. The latest change came on Oct 28, 2026, when HC Wainwright & Co. initiated coverage of Lakewood-Amedex with a Buy rating and a $3 price target.
Price Target Range — 1 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months
